KLAB has sold its Anafortan and Cefi trade mark to M/s.NPIL. KLAB has given exclusive rights for their patennts for Camylofin Inj. Camylofin and Paracetamol tablets, Camylofin and Paramacetamol suspension / drops for the Indian market. Further Non exclusive rights of KLAB's patent of Cefixime, Cloxacillin and Lactobcillus and Cefixime OD tablets to M/s.NPIL.